These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 17177046)
1. Pulmonary bacterial co-infection in children ventilated for severe respiratory syncytial virus bronchiolitis is common. Thorburn K; Van Saene H Intensive Care Med; 2007 Mar; 33(3):565. PubMed ID: 17177046 [No Abstract] [Full Text] [Related]
2. Ribavarin in ventilated respiratory syncytial virus bronchiolitis: a randomized, placebo-controlled trial. Khoshoo V; Edell D Am J Respir Crit Care Med; 2000 Jul; 162(1):333-4. PubMed ID: 10903266 [No Abstract] [Full Text] [Related]
3. Dexamethasone in children mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus: a randomized controlled trial. van Woensel JB; Vyas H; Crit Care Med; 2011 Jul; 39(7):1779-83. PubMed ID: 21460709 [TBL] [Abstract][Full Text] [Related]
4. Through the mists of treatment: managing severe bronchiolitis. Argent AC Pediatr Crit Care Med; 2008 Nov; 9(6):659-61. PubMed ID: 18997600 [No Abstract] [Full Text] [Related]
11. A comparison of characteristics and outcomes in severe human metapneumovirus and respiratory syncytial virus infections in children treated in an intensive care unit. Eggleston HA; Gunville CF; Miller JI; Sontag MK; Mourani PM Pediatr Infect Dis J; 2013 Dec; 32(12):1330-4. PubMed ID: 23811741 [TBL] [Abstract][Full Text] [Related]
12. CPAP and HFOV: different guises of the same underlying intensive care strategy for supporting RSV bronchiolitis. Tasker RC Intensive Care Med; 2008 Sep; 34(9):1560-1. PubMed ID: 18500422 [No Abstract] [Full Text] [Related]
13. Mechanical ventilation drives inflammation in severe viral bronchiolitis. Hennus MP; van Vught AJ; Brabander M; Brus F; Jansen NJ; Bont LJ PLoS One; 2013; 8(12):e83035. PubMed ID: 24349427 [TBL] [Abstract][Full Text] [Related]
14. Respiratory syncytial virus and rhinovirus severe bronchiolitis are associated with distinct nasopharyngeal microbiota. Mansbach JM; Hasegawa K; Henke DM; Ajami NJ; Petrosino JF; Shaw CA; Piedra PA; Sullivan AF; Espinola JA; Camargo CA J Allergy Clin Immunol; 2016 Jun; 137(6):1909-1913.e4. PubMed ID: 27061249 [No Abstract] [Full Text] [Related]
16. Pattern of drug usage in bronchiolitis. Nahata MC; Schad PA J Clin Pharm Ther; 1994 Apr; 19(2):117-8. PubMed ID: 8071391 [TBL] [Abstract][Full Text] [Related]
17. Alpha-2A-interferon for treatment of bronchiolitis caused by respiratory syncytial virus. Chipps BE; Sullivan WF; Portnoy JM Pediatr Infect Dis J; 1993 Aug; 12(8):653-8. PubMed ID: 8414778 [TBL] [Abstract][Full Text] [Related]
18. Management and prevention strategies for respiratory syncytial virus (RSV) bronchiolitis in infants and young children: a review of evidence-based practice interventions. Cooper AC; Banasiak NC; Allen PJ Pediatr Nurs; 2003; 29(6):452-6. PubMed ID: 14743842 [TBL] [Abstract][Full Text] [Related]
19. IFN-gamma response and IL-8 plasma levels in neonates with respiratory syncytial virus bronchiolitis. Schultz C; Richter N; Möller JC; Bucsky P Eur Respir J; 2001 Feb; 17(2):321-4. PubMed ID: 11334138 [No Abstract] [Full Text] [Related]
20. DNase treatment for atelectasis in infants with severe respiratory syncytial virus bronchiolitis. Merkus PJ; de Hoog M; van Gent R; de Jongste JC Eur Respir J; 2001 Oct; 18(4):734-7. PubMed ID: 11716180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]